Tag Archives: insurance

A Call to Conscience-Pre-existing condition changes and Limits on Patient Legal Options

This is a quick blog about some disturbing issues pending in Congress.  First is the new call to eliminate pre-existing condition protection. The intent is to repeal the protection and leave the matter to the states.  In the past there … Continue reading

Posted in Affordable Care Act, aging, consumer protection, Uncategorized | Tagged , , , , , , | Leave a comment

The American Health Care Machine and You: A Call to Conscience–Human Consequences of Turning A Blind Eye

“A nation’s greatness is measured by how it treats its weakest members.” ~ Mahatma Gandhi “Let your conscience be your guide” is a conviction we have not learned as a society when it comes to health care. As a country we … Continue reading

Posted in Affordable Care Act, health access, Health Care Reform, health insurance, medical bankruptcy, patient care, policy and politics, public dialogue | Tagged , , , , , , , , , , , , , , , , , | Leave a comment

The American Health Care Machine and You: A Call to Conscience– $40 million executive bonus and what $40 million could cover

 Health care is a top issue in the presidential race, but unmentioned is the $40. 2 million Golden Parachute for Humana’s CEO if the proposed merger with Aetna is approved.  “Humana CEO Bruce Broussard is primed for a huge payday. … Continue reading

Posted in Affordable Care Act, aging, budget cuts, community action, consumer protection, Economy, Health Care Reform, health care stories, health insurance, hospitals, long-term care, Medicare, patient care, patients' voice, policy and politics, public dialogue, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , | Leave a comment

Congress Tackles Drug Prices: Much Bipartisan Support; and Recent Trends in Drug Costs Here and What Other Countries Pay

Finally it looks like Congress might just re-visit Medicare Part D and let Medicare negotiate rates with drug companies.   See charts below: http://www.statnews.com/2015/12/01/stat-harvard-drug-prices-poll/  The VA and Medicaid can negotiate rates. Senate Special Committee on Aging holds drug costs hearing December … Continue reading

Posted in aging, Economy, media, Medicare, pharmaceutical companies, policy and politics, politics, prescription drugs, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Drug Clinical Trials, Comparative Effectiveness, and much more

In 2013, I ran a 2 column series on how pharmaceutical products are tested and evaluated before going on the market (see link below). In light of the current discussions about drug prices, here are some things you might be … Continue reading

Posted in business, consumer protection, pharmaceutical companies, prescription drugs | Tagged , , , , , , , , , , , , , , , , | Leave a comment

What You CAN Do About Prescription Drug Costs

What American’s Think About Prices and What You Can Do                      “Corporations now spend at least $2.6 billion a year lobbying Congress—more than the $2 billion taxpayers spend funding the House and the Senate.”  The Week, July 31, 2015 What … Continue reading

Posted in consumer protection, Economy, health insurance, medical bankruptcy, Medicare, patients' voice, policy and politics, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , , , , | Leave a comment

Women’s Health: A Brief Historical Context of Contraceptives and Adoptions

As an aging woman, I have been following  the furor over women’s health with great interest. There are many issues  young women today don’t know.  To understand where we are and what we have accomplished, it is important to remember … Continue reading

Posted in Affordable Care Act, consumer protection, Health Care Reform, patients' voice | Tagged , , , , , , , , , | 3 Comments

Changing Aging Care: Personal, not Institutional Care–What Can Be Done and What You Can Do; and my new advisory and board appointments

The Limits Of Medicare “Medicare is great for medical care, but it simply does not cover the support and personal care services that frail elderly people need. The current system cannot support those needs—the way we pay for care is … Continue reading

Posted in aging, community based care, Health Care Reform, health insurance, long-term care, Medicare, policy and politics | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | 3 Comments

A New Direction for O’ConnorReport: ACA “Watch Dog” and new Showcases of Success

The Supreme Court’s decision validates the core of the Affordable Care Act.  Still much more remains to assure safety, quality and value (bang for the buck). To date, I have focused on the systems’ ills. What we heard loud and … Continue reading

Posted in consumer protection, Health Care Reform, hospitals, Medicare, patients' voice | Tagged , , , , , , , , , , , , , , , | 1 Comment

Did You Know? New Series on Long-term Care. PART I: Medicare Can’t Negotiate Drug Prices—VA and Medicaid Can

The Presidential election season is once again upon us.  The Affordable Care Act deals with some Medicare issues, but some key ones are not addressed. Pharmaceutical costs and long-term care are two of them.  Here is a question you can … Continue reading

Posted in business, consumer protection, Health Care Reform, medical bankruptcy, Medicare, patients' voice, policy and politics, technology and pharmaceutical costs | Tagged , , , , , , , , , , , , , | Leave a comment